John P. Fruehauf, MD, UC Irvine Health, explains Practice-Changing Impact of Presented Data | Durability to the Benefit of Immunotherapy at MOASC 2018
Practice-Changing Impact of Presented Data | Durability to the Benefit of Immunotherapy
John P. Fruehauf, MD, UC Irvine Health, explains Practice-Changing Impact of Presented Data | Durability to the Benefit of Immunotherapy at MOASC 2018